Adjustable continence therapy (ProACT/ACT^TM) with periurethral balloons for treatment of stress urinary incontinence: a narrative review.

ABSTRACT:

Background and objective

First-line surgical management of stress urinary incontinence (SUI) currently involves implantation of an artificial urinary sphincter (AUS) in male patients and midurethral sling in female patients. Still, there is demand for a less invasive treatment option without the need to use a device during voiding. Since its first description in 2005, many clinics have implemented adjustable continence therapy balloons in male (ProACT^TM) and female patients (ACT^TM).

Methods

Publications on the use of ProACT/ACT^TM were reviewed from 2002 until September 2022, focusing on functional and safety outcomes, including predictors of treatment failure and complications.

Key content and findings

Most publications report the use

SUBMITTER: den Hoedt S 

PROVIDER: S-EPMC11399041 | biostudies-literature | 2024 Aug

REPOSITORIES: biostudies-literature